Key points are not available for this paper at this time.
To further optimize output from electrochemical sensing technology and minimize human intervention, machine learning (ML) models are capable of imparting data-driven predictions. The present work focuses on developing a miniaturized EC sensing platform for the simultaneous detection of neurotransmitters such as dopamine (DA) and serotonin or 5-hydroxytryptamine (5-HT). A modified carbon thread-based miniaturized device (CTMD) was developed using a CO 2 laser scriber to detect dopamine and serotonin. The devices showed a linear range for DA and 5-HT as 0.5 μM – 150 μM and 0.5 μM – 200 μM, respectively. The Limit of detection (LOD) and Limit of quantification (LOQ) for DA and 5-HT were 0.25 μM, 0.76 μM (R 2 = 0.99, N = 3), and 0.22 μM, 0.78 μM (R 2 = 0.98, N = 3), respectively. Further, real sample analysis in blood serum was performed, demonstrating good recovery and selectivity. Finally, ML prediction was performed over 100 % of the generated data through analytical methods, whereas 80% of the data was used for training purposes, and 20% of the data was used for testing purposes. Various ML regression models such as linear regression, decision tree, k-NN, Support vector regression, gradient, adaptive boosting, and random forest were used to obtain the best accurate prediction, low error values, and increased R2-scores. Apart from support vector and linear regression, all other techniques provided the best R2-scores of over 0.98 with low error values. Based on the obtained results, the fabricated device, including the ML approach, can effectively be leveraged in diagnostics devices.
Kumar et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: